| Schedule of Earnings Per Share, Basic and Diluted |
The following table sets forth the computation of basic and diluted net income attributable to common stockholders for both the three and nine months ended September 30, 2020 and 2019 (in thousands, except per share amounts): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
September 30, | | Nine Months Ended
September 30, | | 2020 | | 2019 | | 2020 | | 2019 | | Income attributable to common stockholders: | | | | | | | | | Net income | $ | 3,306 | | | $ | 1,360 | | | $ | 9,321 | | | $ | 17,736 | | | Dividends and accretion related to Series A Preferred Stock: | | | | | | | | | Cash dividends declared | (3,968) | | | (3,852) | | | (11,817) | | | (11,192) | | | PIK dividends declared | (1,190) | | | (1,156) | | | (3,545) | | | (3,358) | | | Accretion of discount | (1,587) | | | (1,511) | | | (4,702) | | | (4,319) | | | | (3,439) | | | (5,159) | | | (10,743) | | | (1,133) | | | Undistributed earnings allocated using the two-class method | — | | | — | | | — | | | — | | | Net loss attributable to common stockholders | $ | (3,439) | | | $ | (5,159) | | | $ | (10,743) | | | $ | (1,133) | | | Three Months Ended
September 30, | | Nine Months Ended
September 30, | | 2020 | | 2019 | | 2020 | | 2019 | | Weighted average number of shares of Common Stock outstanding | 72,377 | | | 66,696 | | | 69,521 | | | 65,625 | | | Additional shares outstanding if Series A Preferred Stock is converted to Common Stock | 15,873 | | | 15,408 | | | 15,756 | | | 14,926 | | | Total shares outstanding if Series A Preferred Stock is converted to Common Stock | 88,250 | | | 82,104 | | | 85,277 | | | 80,551 | | | Percentage of shares allocable to Series A Preferred Stock | 18.0 | % | | 18.8 | % | | 18.5 | % | | 18.5 | % | | Weighted average number of shares of Common Stock outstanding: | | | | | | | | | Basic | 72,377 | | | 66,696 | | | 69,521 | | | 65,625 | | | Effect of dilutive securities: | | | | | | | | | Warrants | — | | | — | | | — | | | — | | | Stock options | — | | | — | | | — | | | — | | | Restricted stock units | — | | | — | | | — | | | — | | | Diluted | 72,377 | | | 66,696 | | | 69,521 | | | 65,625 | | | Net loss per share attributable to common stockholders: | | | | | | | | | Basic and diluted | $ | (0.05) | | | $ | (0.08) | | | $ | (0.15) | | | $ | (0.02) | |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
As of September 30, 2020 and 2019, the following potential Common Stock equivalents were excluded from the computation of diluted net loss per share for the respective periods ending on these dates since the impact of inclusion was anti-dilutive (in thousands): | | | | | | | | | | | | | | 2020 | | 2019 | | Series A Preferred Stock | 15,873 | | | 15,408 | | | Restricted stock units | 3,096 | | | 2,887 | | | Stock options | 7,239 | | | 9,312 | | | Warrants | 18,128 | | | 18,128 | | | Total | 44,336 | | | 45,735 | |
|